Live Breaking News & Updates on Antony Blanc|Page 5
Stay updated with breaking news from Antony blanc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Accesswire. The AP news staff was not involved in its creation. CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic April 19, 2021 GMT Review process started with submission of first CVnCoV data package TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 19, 2021 / The CureVac Swiss AG, the Swiss subsidiary of CureVac N.V. (Nasdaq:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced initiation of a rolling submission for CVnCoV, the company’s mRNA based COVID-19 vaccine candidate, for the use in Switzerland. The application for authorization was submitted to Swissmedic, the country’s authority responsible for the authorization and supervision of therapeutic products including vaccines. ....
Investegate |CureVac Announcements | CureVac: CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Sarah Fakih Thank you. Good morning, good afternoon, and welcome to our conference call. My name is Sarah Fakih. I m the vice president of investor relations at CureVac. Please let me introduce today s speakers. On the call with me are Franz Haas, the chief executive officer of CureVac; Pierre Kemula, our chief financial officer; and Ulrike Gnad-Vogt, our interim chief development officer. Mariola Fotin-Mleczek, the CureVac chief technology officer will be available for the Q&A session after the presentation. Please note that this call is being webcast live and will be archived on the events and presentations section under investor relations on our website. ....
CureVac (CVAC) Q4 2020 Earnings Call Transcript msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
DGAP-News: CureVac / Key word(s): Quarter Results/Annual Results CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020 15.04.2021 / 13:30 CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020 - COVID-19 vaccine candidate: CVnCoV in final stage of clinical development and believed to be well on track to provide data for conditional approval based on EMA rolling submission - Pivotal Phase 2b/3 in Europe and Latin America fully recruited with over 40,000 participants. Interim analysis for vaccine efficacy expected in Q2 2021 - Phase 2a trial in Peru and Panama amended for addition of secondary endpoint for vaccine efficacy in total population with a focus on participants over the age of 60 ....